Company: Novartis
Posted by CardioRep_NVS_SE_8830 · March 16, 2026
Tags: strategy, career, quota
generics have FDA approval.
when they launch, hospital systems move fast.
leqvio needs infusion infrastructure.
pelacarsen has no approval date.
asked my RD for a real 2027 transition plan.
got a slide deck.
anyone getting more than that.
10 upvotes · 5 comments